In prostate cancer, MAGEA11 is an androgen responsive gene and, following exposure of cells to androgens, co-localises to the nucleus with AR, where it functions as an AR co-regulator increasing AR transcriptional activity [12]. This evidence concerns the gene AR and prostate cancer.